Inhibition of cellular transdifferentiation by losartan minimizes but does not reverse type 2 diabetes-induced renal fibrosis

Hypothesis/Introduction: Transformer Growth Factor (TGF-β1) and angiotensin II (AngII) induce epithelial mesenchymal transition (EMT) and myofibroblastic transdifferentiation (MFT) contributing to renal fibrosis. The present study evaluated the capacity of an AT1 receptor blocker (losartan) to induc...

Full description

Bibliographic Details
Main Authors: Carine P Arnoni, Edgar Maquigussa, Clévia S Passos, Luciana G Pereira, Mirian A Boim
Format: Article
Language:English
Published: SAGE Publications 2015-09-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320313497817